Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5163675 | 0.67 | DDB1 (0.31) | — | |
| SCHEMBL2733229 | 0.66 | DDB1 (0.31) | — | |
| SCHEMBL2731767 | 0.66 | — | — | |
| SCHEMBL3825820 | 0.65 | CRBN (0.40) | ALDH1A1 | |
| SCHEMBL3958832 | 0.65 | CRBN (0.40) | ALDH1A1 | |
| SCHEMBL278231 | 0.62 | CRBN (0.41) | — | |
| SCHEMBL28098653 | 0.61 | CTSK (0.36) | CTSK | |
| SCHEMBL346851 | 0.59 | CRBN (0.41) | ALDH1A1 | |
| SCHEMBL19255977 | 0.59 | CRBN (0.41) | ALDH1A1 | |
| SCHEMBL7712073 | 0.57 | CRBN (0.44) | CTSK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020107395-A1 | Process for production of gabapentin intermediate | TEVA PHARMACEUTICALS INDUSTRIES LTD. (IL) | 2002-08-08 | — | — | US | claimed |
| EP-1939170-B1 | PROCESS FOR THE PREPARATION OF GABAPENTIN HYDROCHLORIDE | NHWA PHARMA CORP (CN) | 2017-07-12 | — | — | EP | disclosed |
| US-20020107395-A1 | Process for production of gabapentin intermediate | TEVA PHARMACEUTICALS INDUSTRIES LTD. (IL) | 2002-08-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020107395-A1 | Process for production of gabapentin intermediate | OGDH, BCKDK, GABRE | CTSK 1524/4885ALDH1A1 794/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.